Endocannabinoid modulation of dopaminergic motor circuits

There is substantial evidence supporting a role for the endocannabinoid system as a modulator of the dopaminergic activity in the basal ganglia, a forebrain system that integrates cortical information to coordinate motor activity regulating signals. In fact, the administration of plant-derived, synt...

Full description

Bibliographic Details
Main Authors: Teresa eMorera-Herreras, Cristina eMiguelez, Asier eAristieta, José Ángel eRuiz-Ortega, Luisa eUgedo
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-06-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00110/full
_version_ 1828484149494677504
author Teresa eMorera-Herreras
Teresa eMorera-Herreras
Cristina eMiguelez
Asier eAristieta
José Ángel eRuiz-Ortega
José Ángel eRuiz-Ortega
Luisa eUgedo
author_facet Teresa eMorera-Herreras
Teresa eMorera-Herreras
Cristina eMiguelez
Asier eAristieta
José Ángel eRuiz-Ortega
José Ángel eRuiz-Ortega
Luisa eUgedo
author_sort Teresa eMorera-Herreras
collection DOAJ
description There is substantial evidence supporting a role for the endocannabinoid system as a modulator of the dopaminergic activity in the basal ganglia, a forebrain system that integrates cortical information to coordinate motor activity regulating signals. In fact, the administration of plant-derived, synthetic or endogenous cannabinoids produces several effects on motor function. These effects are mediated primarily through the CB1 receptors that are densely located in the dopamine-enriched basal ganglia networks, suggesting that the motor effects of endocannabinoids are due, at least in part, to modulation of dopaminergic transmission.On the other hand, there are profound changes in CB1 receptor cannabinoid signaling in the basal ganglia circuits after dopamine depletion (as happens in Parkinson´s disease) and following L-DOPA replacement therapy. Therefore, it has been suggested that endocannabinoid system modulation may constitute an important component in new therapeutic approaches to the treatment of motor disturbances. In this article we will review studies supporting the endocannabinoid modulation of dopaminergic motor circuits.
first_indexed 2024-12-11T08:50:50Z
format Article
id doaj.art-b24e8c12015b4041917044df413ebb04
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-11T08:50:50Z
publishDate 2012-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-b24e8c12015b4041917044df413ebb042022-12-22T01:14:01ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122012-06-01310.3389/fphar.2012.0011027203Endocannabinoid modulation of dopaminergic motor circuitsTeresa eMorera-Herreras0Teresa eMorera-Herreras1Cristina eMiguelez2Asier eAristieta3José Ángel eRuiz-Ortega4José Ángel eRuiz-Ortega5Luisa eUgedo6Faculty of Medicine and Dentistry. University of the Basque CountryFaculty of Pharmacy. University of the Basque CountryFaculty of Medicine and Dentistry. University of the Basque CountryFaculty of Medicine and Dentistry. University of the Basque CountryFaculty of Medicine and Dentistry. University of the Basque CountryFaculty of Pharmacy. University of the Basque CountryFaculty of Medicine and Dentistry. University of the Basque CountryThere is substantial evidence supporting a role for the endocannabinoid system as a modulator of the dopaminergic activity in the basal ganglia, a forebrain system that integrates cortical information to coordinate motor activity regulating signals. In fact, the administration of plant-derived, synthetic or endogenous cannabinoids produces several effects on motor function. These effects are mediated primarily through the CB1 receptors that are densely located in the dopamine-enriched basal ganglia networks, suggesting that the motor effects of endocannabinoids are due, at least in part, to modulation of dopaminergic transmission.On the other hand, there are profound changes in CB1 receptor cannabinoid signaling in the basal ganglia circuits after dopamine depletion (as happens in Parkinson´s disease) and following L-DOPA replacement therapy. Therefore, it has been suggested that endocannabinoid system modulation may constitute an important component in new therapeutic approaches to the treatment of motor disturbances. In this article we will review studies supporting the endocannabinoid modulation of dopaminergic motor circuits.http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00110/fullBasal GangliaDopamineElectrophysiologyEndocannabinoidsMotor circuits
spellingShingle Teresa eMorera-Herreras
Teresa eMorera-Herreras
Cristina eMiguelez
Asier eAristieta
José Ángel eRuiz-Ortega
José Ángel eRuiz-Ortega
Luisa eUgedo
Endocannabinoid modulation of dopaminergic motor circuits
Frontiers in Pharmacology
Basal Ganglia
Dopamine
Electrophysiology
Endocannabinoids
Motor circuits
title Endocannabinoid modulation of dopaminergic motor circuits
title_full Endocannabinoid modulation of dopaminergic motor circuits
title_fullStr Endocannabinoid modulation of dopaminergic motor circuits
title_full_unstemmed Endocannabinoid modulation of dopaminergic motor circuits
title_short Endocannabinoid modulation of dopaminergic motor circuits
title_sort endocannabinoid modulation of dopaminergic motor circuits
topic Basal Ganglia
Dopamine
Electrophysiology
Endocannabinoids
Motor circuits
url http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00110/full
work_keys_str_mv AT teresaemoreraherreras endocannabinoidmodulationofdopaminergicmotorcircuits
AT teresaemoreraherreras endocannabinoidmodulationofdopaminergicmotorcircuits
AT cristinaemiguelez endocannabinoidmodulationofdopaminergicmotorcircuits
AT asierearistieta endocannabinoidmodulationofdopaminergicmotorcircuits
AT joseangeleruizortega endocannabinoidmodulationofdopaminergicmotorcircuits
AT joseangeleruizortega endocannabinoidmodulationofdopaminergicmotorcircuits
AT luisaeugedo endocannabinoidmodulationofdopaminergicmotorcircuits